Systemic risks when leaders lose cognitive capacity: Structural failures in governance and accountability

Indigenous governance systems universally incorporate mechanisms to address cognitive decline in leaders, such as the Māori practice of *whakawātea* (clearing the path for renewal) or the Navajo concept of *Hózhǫ́* (harmony), which demands periodic reassessment of leadership fitness. These systems contrast sharply with Western corporate models, where cognitive decline is treated as a private medical issue rather than a governance failure. The absence of such structures in modern institutions reflects a colonial legacy that prioritizes individualism over communal well-being.

Historical precedents abound where unchecked executive dysfunction led to systemic collapse, from the dementia of King George III precipitating the American Revolution to the cognitive decline of corporate leaders like Enron’s Kenneth Lay. The 2008 financial crisis was exacerbated by executives operating with impaired judgment, yet no governance reforms addressed cognitive screening. Medieval European monarchies often used regency councils to manage such scenarios, a model entirely absent in modern corporate governance.

Cross-cultural comparisons reveal that societies with decentralized leadership structures, such as the Swiss collegial executive system, distribute cognitive risk across multiple actors, reducing single-point failures. In contrast, the U.S. model of a unitary CEO concentrates cognitive risk in one individual, mirroring the vulnerabilities of authoritarian regimes where leadership succession is opaque. Scandinavian corporate models, which mandate board-level cognitive assessments, demonstrate that cultural norms around transparency can mitigate such risks.

Neuroscience confirms that executive dysfunction in aging leaders is often undetected due to the 'illusion of control' bias, where high-functioning individuals mask deficits in complex environments. Studies show that 20-30% of adults over 65 exhibit mild cognitive impairment, yet corporate governance lacks standardized screening tools. The Dunning-Kruger effect further exacerbates this, as overconfident leaders may dismiss early warning signs, a phenomenon documented in aviation and healthcare but ignored in corporate settings.

Artistic traditions often symbolize leadership decay through metaphors of physical decay, such as Shakespeare’s *King Lear* or the Māori *whakataukī* (proverb) 'He aha te mea nui o te ao? He tangata, he tangata, he tangata' (What is the most important thing in the world? It is people, it is people, it is people). Spiritual traditions, like the Buddhist concept of *anicca* (impermanence), frame leadership as transient, yet modern institutions resist such humility. These perspectives highlight the ethical dimension of cognitive decline, which materialist frameworks often ignore.

Future scenarios suggest that AI-driven cognitive monitoring could become mandatory for executives, but this risks creating a technocratic elite that pathologizes aging while ignoring structural power imbalances. Alternative models, like cooperative governance where leadership is rotated, could distribute cognitive risk but face resistance from entrenched interests. The rise of 'cognitive capitalism' may further incentivize denial of decline, as leaders are rewarded for short-term performance over long-term sustainability.

Marginalized voices—employees, shareholders, and communities—are systematically excluded from discussions about executive dysfunction, despite bearing the consequences. Whistleblowers who raise concerns about cognitive decline are often silenced or discredited, as seen in cases like Theranos or Boeing. The framing of this issue as a 'medical problem' rather than a governance failure depoliticizes it, preventing collective action to demand structural reforms.